Corporate
Denali Posts Best-in-Class Sanfilippo Data at WORLD Symposium, Eyes Back-to-Back Rare Disease Approvals
3h ago
You're signed outSign in or to get full access.
DT
Denali Therapeutics (DNLI)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Denali Therapeutics.